Abstract

Background: Meta-analysis methods for evaluating interactions are not well described. Assessing interactions with eGFR is particularly challenging due to its non-linear association with risk. We describe methods to evaluate point-wise and overall interactions using an example of hypertension-eGFR interaction on mortality risk. Methods: The applicability of our methods was evaluated in 28 out of 46 cohorts joining the Chronic Kidney Disease Prognosis Consortium (CKD-PC). In each study, eGFR linear splines (knots at each 15 from 15 to 105 ml/min/1.73m²) and their product terms with hypertension were fitted, providing hazard ratios (HRs) for eGFR (vs. eGFR 95) in both hypertensive and non-hypertensive groups. From this model, the interaction was evaluated as the relative HR (rHR) in hypertension vs. non-hypertension at each 1 ml/min/1.73m² of eGFR between 15 and 120 (point-wise interaction). HRs and rHRs for each eGFR value in each cohort were then pooled using random effects models. The overall interaction was assessed as the inverse-variance average of differences in all spline coefficients for the entire range of eGFR between hypertensive vs. non-hypertensive groups. Results: There were 942,429 participants and 69,072 deaths. Low eGFR was associated with increased mortality in the hypertensive (gray line) and non-hypertensive (black line) groups ( figure ). Significant interactions by hypertension status were observed at eGFR range below 60 ml/min/1.73m² at each eGFR value p-interaction<0.05 is noted by “x” in the figure . In this range, the impact of low eGFR on mortality was weaker in the hypertensive group as compared with the non-hypertensive group. Overall interaction test was also significant (P<0.001). Conclusion: We developed and implemented meta-analytic methods to assess point-wise and overall interactions in non-linear regression models. Interactions can be comprehensively evaluated using both methods and should be interpreted based on biological and clinical relevance.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call